10 Best Rising Penny Stocks to Buy According to Analysts
The start of 2025 was characterized by a series of challenges for the US equities across the board.
Posts Tagged ‘NASDAQ:RGLS’
10 Best Short-Term Stocks To Buy Right Now
Thrilling highs, daunting lows, and the energized chase after the next big opportunity – this thoroughly defines the current stock market.
10 Cheapest Stocks Insiders Are Buying Recently
In this article, we will take a detailed look at the 10 cheapest stocks insiders are buying recently.
Regulus Therapeutics Inc. (NASDAQ:RGLS) Q3 2022 Earnings Call Transcript
Operator: Hello, and welcome to the Regulus Therapeutics Inc. Q3 2022 Earnings Conference Call. .
13 Best Biotech Penny Stocks To Buy Now
In this article, we will be taking a look at the 13 best biotech penny stocks to buy now.
5 Biotech Penny Stocks to Buy According to Reddit
In this article, we discuss the 5 biotech penny stocks to buy according to Reddit.
5 Best One Dollar Stocks to Buy Now
In this article, we will be looking at the 5 best one dollar stocks to buy now.
Is Regulus Therapeutics Inc (RGLS) A Good Stock To Buy?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
Should I Buy Regulus Therapeutics Inc (RGLS)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Hedge Funds Are Dumping Regulus Therapeutics Inc (RGLS)
How do we determine whether Regulus Therapeutics Inc (NASDAQ:RGLS) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors...
13G Filing: Biotechnology Value Fund LP and Regulus Therapeutics Inc. (RGLS)
You can access the original SEC filing by clicking here.
13G Filing: Broadfin Capital and Regulus Therapeutics Inc. (RGLS)
The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent...
13G Filing: EcoR1 Capital and Regulus Therapeutics Inc. (RGLS)
You can access the original SEC filing by clicking here.
13G Filing: Biotechnology Value Fund LP and Regulus Therapeutics Inc. (RGLS)
You can access the original SEC filing by clicking here.
Insider Buying at Regulus Therapeutics Inc (RGLS) Sends Stock Soaring
Regulus Therapeutics Inc (NASDAQ:RGLS) shares have jumped $0.30 per share, or 24%, to $1.55 in after hours on Thursday. Traders have bid up shares due to the company disclosing...
How Regulus Therapeutics Inc (RGLS) Stacks Up Against Its Peers
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable...
Why Are These Stocks Deep in Red Today?
Among the losers today are Regulus Therapeutics Inc (NASDAQ:RGLS), Vista Gold Corp.
What’s Going On With These 5 Trending Stocks?
U.S stocks are trading down ever so slightly on this fine Friday afternoon.
Is Regulus Therapeutics Inc (RGLS) Going to Burn These Hedge Funds?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track more than 700 prominent money managers...
Trellus Management’s Top Biotech Stock Picks For Q4
Trellus Management is a New York-based long/short equity hedge fund founded by Adam Usdan in 1994.
RA Capital Is Expecting A Breakthrough Cardiovascular Drug From This Biotech
The biotechnology industry is up by more than 50% over the last year, but these towering returns don't come without great risk and volatility.
Regulus Therapeutics Inc (RGLS), Trevena Inc (TRVN), Juno Therapeutics Inc (JUNO): RA Capital’s Top New Biotech Picks
Peter Kolchinsky’s RA Capital Management filed its latest 13F with the Securities and Exchange Commission in February, and we’ve gone through the data to highlight three of...
Alkermes Plc (ALKS), Quest Diagnostics Inc (DGX): This Week in Biotech
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
This Metric Says You Are Smart to Sell Star Scientific, Inc. (STSI)
Star Scientific, Inc. (NASDAQ:STSI) was in 4 hedge funds' portfolio at the end of March.
Merck & Co., Inc. (MRK), Clovis Oncology Inc (CLVS), Regulus Therapeutics Inc (RGLS): 3 Stocks to Get on Your Watchlist
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
The Coca-Cola Company (KO), Tesla Motors Inc (TSLA) Among Stocks to Sell Near 52-Week Highs
Commodities may be in the midst of a nasty sell-off, and worries about Cyprus' financial ripples continue to persist, yet 2,300 of 4,800 companies in The Motley Fool CAPS Screener...
